BioNTech SE (BNTX)
91.73
-0.28
(-0.30%)
USD |
NASDAQ |
May 10, 16:00
91.73
0.00 (0.00%)
After-Hours: 19:12
BioNTech Gross Profit Margin (Quarterly): 68.50% for March 31, 2024
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 68.50% |
| December 31, 2023 | 87.89% |
| September 30, 2023 | 81.93% |
| June 30, 2023 | 2.86% |
| March 31, 2023 | 92.48% |
| December 31, 2022 | 95.71% |
| September 30, 2022 | 78.25% |
| June 30, 2022 | 76.08% |
| March 31, 2022 | 79.70% |
| December 31, 2021 | 89.46% |
| September 30, 2021 | 80.10% |
| June 30, 2021 | 83.35% |
| Date | Value |
|---|---|
| March 31, 2021 | 88.62% |
| December 31, 2020 | 88.13% |
| September 30, 2020 | 89.93% |
| June 30, 2020 | 86.57% |
| March 31, 2020 | 78.70% |
| December 31, 2019 | 84.02% |
| September 30, 2019 | 85.24% |
| June 30, 2019 | 78.71% |
| March 31, 2019 | 87.75% |
| December 31, 2018 | 92.98% |
| September 30, 2018 | 86.38% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
2.86%
Minimum
Jun 2023
95.71%
Maximum
Dec 2022
79.81%
Average
83.68%
Median
Gross Profit Margin (Quarterly) Benchmarks
| Pfizer Inc | 77.29% |
| Moderna Inc | 42.52% |
| Autolus Therapeutics PLC | -- |
| Novavax Inc | 38.84% |
| BioVie Inc | -- |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | 0.54% |
| Return on Assets | 0.49% |
| Return on Invested Capital | 0.54% |
| Profit Margin (Quarterly) | -168.0% |
| Operating Margin (Quarterly) | -270.4% |
| Return on Net Operating Assets | 1.95% |